Kapi'olani Medical Center for Women and Children — Honolulu, Hawaii

Kapi'olani Medical Center for Women and Children is a clinical research site located in Honolulu, Hawaii, United States 96826.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Kapi'olani Medical Center for Women and Children has participated in 17 clinical trials with 5 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Hyperbilirubinemia, Neonatal, Ovarian Cancer.

Sponsors: Genmab, InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company, Morphotek.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Honolulu

Browse all research sites in Hawaii · View every site in Honolulu

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kapi'olani Medical Center for Women and Children?

Kapi'olani Medical Center for Women and Children has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kapi'olani Medical Center for Women and Children conducted?

Kapi'olani Medical Center for Women and Children has 17 clinical trials on record, with 5 currently active. Their work covers Platinum-resistant Ovarian Cancer, Hyperbilirubinemia, Neonatal, Ovarian Cancer.

Is Kapi'olani Medical Center for Women and Children accredited by Crixeo Clinical Trials?

Kapi'olani Medical Center for Women and Children has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kapi'olani Medical Center for Women and Children?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.